Logix Biosciences, INC
At a glance
EmployeesNot reported
In business since2023
HeadquartersMonterey, CA
SAM.gov UEIVRJLPVYJK265
Logix Biosciences develops a patented antimicrobial composition called LBX242, which is engineered to act as an antibacterial agent that disrupts bacterial cell walls, an antiviral agent against enveloped respiratory viruses, and an angiogenic agent that promotes tissue repair. The company's platform comprises two parallel patented assets derived from botanical and synthetic sources. The company is a clinical-stage pharmaceutical firm serving the treatment of multi-drug-resistant bacterial pathogens and common cold viruses.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Logix Biosciences, INC | Monterey | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.